A Multi-centric Study to Assess the Efficacy of Sigmart in Subjects With Recurrent Angina After Coronary Revascularization
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The multi-centric, open label, single arm and self controlled study is planned to assess the
efficacy of orally administered Sigmart in subjects with recurrent angina after coronary
revascularization. The primary objective of this study is to demonstrate that orally
administered Sigmart can improve the major Exercise Tolerance Test (ETT) result in recurrent
angina subjects.